Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulka Vaishampayan

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
ISRN Oncology|June 30, 2012
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate CancerShin Ogita, Sheela Tejwani, Lance Heilbrun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2004
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancerHaihao Sun, Andrew Sloan, Thomas J Mangner, et al.
Investigational New Drugs|March 4, 2005
Phase II trial of fenretinide in advanced renal carcinomaUlka Vaishampayan, Lance K Heilbrun, Ralph E Parchment, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|October 3, 2008
Longitudinal analysis of a model to predict quality of life in prostate cancer patients and their spousesTrace S Kershaw, Darlene W Mood, Gail Newth, et al.
Scientific Reports|November 23, 2023
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growthBarani Govindarajan, Diego Sbrissa, Mark Pressprich, et al.
Urology|April 3, 2003
Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancerMaha Hussain, David C Smith, Basil F El-Rayes, et al.
Abdominal Radiology (New York)|February 5, 2021
Percutaneous cryoablation of adrenal metastases: technical feasibility and safetyHussein D Aoun, Peter J Littrup, Bashar Nahab, et al.
Journal for Immunotherapy of Cancer|October 19, 2017
Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapyGhayathri Jeyakumar, Seongho Kim, Naresh Bumma, et al.
Clinical Genitourinary Cancer|April 13, 2016
Phase II Study of Pazopanib and Paclitaxel in Patients With Refractory Urothelial CancerSujata Narayanan, Anthony Lam, Ulka Vaishampayan, et al.
Cold Spring Harbor Molecular Case Studies|April 28, 2022
Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancerHannah N Bell, Chandan Kumar-Sinha, Rahul Mannan, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
ISRN Oncology|June 30, 2012
Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate CancerShin Ogita, Sheela Tejwani, Lance Heilbrun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2004
Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancerHaihao Sun, Andrew Sloan, Thomas J Mangner, et al.
Investigational New Drugs|March 4, 2005
Phase II trial of fenretinide in advanced renal carcinomaUlka Vaishampayan, Lance K Heilbrun, Ralph E Parchment, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|October 3, 2008
Longitudinal analysis of a model to predict quality of life in prostate cancer patients and their spousesTrace S Kershaw, Darlene W Mood, Gail Newth, et al.
Scientific Reports|November 23, 2023
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growthBarani Govindarajan, Diego Sbrissa, Mark Pressprich, et al.
Urology|April 3, 2003
Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancerMaha Hussain, David C Smith, Basil F El-Rayes, et al.
Abdominal Radiology (New York)|February 5, 2021
Percutaneous cryoablation of adrenal metastases: technical feasibility and safetyHussein D Aoun, Peter J Littrup, Bashar Nahab, et al.
Journal for Immunotherapy of Cancer|October 19, 2017
Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapyGhayathri Jeyakumar, Seongho Kim, Naresh Bumma, et al.
Clinical Genitourinary Cancer|April 13, 2016
Phase II Study of Pazopanib and Paclitaxel in Patients With Refractory Urothelial CancerSujata Narayanan, Anthony Lam, Ulka Vaishampayan, et al.
Cold Spring Harbor Molecular Case Studies|April 28, 2022
Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancerHannah N Bell, Chandan Kumar-Sinha, Rahul Mannan, et al.
Pageof 18